Should Living Donors Be Used for Patients with Heptocellular Cancer? Elizabeth Pomfret, MD

1,092 views · Published 21 December 2012 · 1:06:49 · Indexed 8 November 2026

Channel: The University of Chicago · 2012 · Education

Watch on YouTube

Elizabeth Pomfret, MD, PhD, FACS, Chair of the Department of Transplantation at the Lahey Clinic, debates if living donors should be used for patients with heptocellular cancer (HCC).

Organ transplantation raises almost every important medical ethical issue, including: standards for determining death, informed consent, the fair allocation of scarce resources, research on human subjects, global health concerns, and more. The MacLean Center's Seminar Series has examined Ethical Issues in Organ Transplantation.

This year's interdisciplinary seminar series was organized by Mark Siegler, MD, Director of the MacLean Center. The seminars are cosponsored by the Transplant Center at the University of Chicago Medicine.

Learn more about the MacLean Center for Clinical Medical Ethics at http://medicine.uchicago.edu/centers/ethics/welcome.html

➡ Subscribe: http://bit.ly/UCHICAGOytSubscribe   

About #UChicago:
Since its founding in 1890, the University of Chicago has been a destination for rigorous inquiry and field-defining research. This transformative academic experience empowers students and scholars to challenge conventional thinking in pursuit of original ideas.

#UChicago on the Web:
Home: http://bit.ly/UCHICAGO-homepage
News: http://bit.ly/UCHICAGO-news 
Facebook: http://bit.ly/UCHICAGO-FB  
Twitter: http://bit.ly/UCHICAGO-TW   
Instagram: http://bit.ly/UCHICAGO-IG  

University of Chicago on YouTube:
https://www.youtube.com/uchicago ***

ACCESSIBILITY: If you experience any technical difficulties with this video or would like to make an accessibility-related request, please email [email protected].

More from this channel